NAT-LETROZOLE
Identification of Nat-Letrozole
| No description |
Google image searchProduct monograph
Active ingredient
letrozole, 2.5 MG
DIN: 02421585
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 03-FEB-2015
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02B — HORMONE ANTAGONISTS AND RELATED AGENTS (ATC, ATC/DDD)
- L02BG — Enzyme inhibitors (ATC, ATC/DDD)
- L02BG04 — LETROZOLE (ATC/DDD)
Reference brand drug: Femara
Pharmaceutical standard: USP
